The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Relationship of Src activity and prior oxaliplatin on outcomes after hepatectomy for metastatic colorectal cancer.
Van Karlyle Morris
No relevant relationships to disclose
Nila Parikh
No relevant relationships to disclose
Michael J. Overman
No relevant relationships to disclose
Zhi-Qin Jiang
No relevant relationships to disclose
Dipen M Maru
No relevant relationships to disclose
Paul Elvin
Employment or Leadership Position - AstraZeneca
Scott Kopetz
Research Funding - AstraZeneca; Bristol-Myers Squibb
Gary E. Gallick
Research Funding - AstraZeneca